Business Segments · G&A

Business Segments — G&A

Amgen Business Segments — G&A decreased by 24.9% to $468.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 24.6%, from $621.00M to $468.00M. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2024
Last reportedQ1 2026
Rolls up toG&A

How to read this metric

A decrease relative to revenue indicates improved operational leverage and corporate efficiency.

Detailed definition

Covers the overhead costs of operating the business, including executive compensation, legal, finance, and corporate inf...

Peer comparison

Standard 'G&A' expense reported by all public companies.

Metric ID: amgn_segment_reportable_segment_general_and_administrative

Historical Data

7 periods
 Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$604.00M$574.00M$508.00M$621.00M$554.00M$623.00M$468.00M
QoQ Change-5.0%-11.5%+22.2%-10.8%+12.5%-24.9%
YoY Change+2.8%-3.5%+22.6%-24.6%
Range$468.00M$623.00M
CAGR-15.6%
Avg YoY Growth-0.7%
Median YoY Growth-0.3%

Frequently Asked Questions

What is Amgen's business segments — g&a?
Amgen (AMGN) reported business segments — g&a of $468.00M in Q1 2026.
How has Amgen's business segments — g&a changed year-over-year?
Amgen's business segments — g&a decreased by 24.6% year-over-year, from $621.00M to $468.00M.
What does business segments — g&a mean?
The administrative costs of running the company's corporate operations.